Nevro (NYSE:NVRO) said today that it won FDA approval for and launched its Senza Omnia spinal cord stimulation system. The Senza Omnia is the first and only SCS system designed to deliver Nevro’s proprietary HF10 therapy, as well as other available SCS frequencies, Nevro said in a news release. Redwood City, Calif.–based Nevro’s Omnia system is […]
Neuromodulation/Neurostimulation
Neuromod developer ENeura sells nearly $6 million in debt
ENeura Therapeutics, a neuromod developer, today filed an SEC Form D to confirm the sale of nearly $6 million in a debt offering. The new notice’s first sale was made last week. The Baltimore-based company does not intend for the offering to last for more than one year. ENeura’s offering total was set at nearly […]
Medtronic launches Activa DBS programmer
Medtronic (NYSE:MDT) said yesterday that it commercially launched its Activa patient programmer technology for deep brain stimulation in the U.S. The programmer won FDA approval in July and is designed to combine with a Samsung mobile device to allow patients to manage DBS therapy in a simple and discrete way. Medtronic said more than 150,000 patients […]
Neuronetics inks deal with TMS provider for NeuroStar depression device
Neuronetics (NSDQ:STIM) said today that it entered into a partnership with Success TMS to offer Neuronetics’ NeuroStar advanced therapy system as its preferred transcranial magnetic stimulation device across six states. The NeuroStar system is designed to use strong magnetic fields to stimulate areas of the brain associated with mood in the treatment of patients with […]
ShiraTronics raises $33m Series A for migraine neuromod program
ShiraTronics said yesterday that it completed a $33 million Series A financing round for the migraine headache neuromodulation treatment it’s developing and announced the appointment of Lynn Elliott as president & CEO. Elliott is a three-decade veteran of the industry, having previously worked at Guidant, Boston Scientific and Spinal Modulation before assuming his new role […]
The top 10 medical disruptors of 2020
For the past 17 years, the Cleveland Clinic has predicted what the top 10 medical disruptors will be for the following year. The list of technologies, cultivated by a panel of physicians and scientists at the clinic, was led by Dr. Michael Roizen, emeritus chief wellness officer. “Healthcare is ever-changing and we anticipate that these […]
DeviceTalks Q&A: Talking targeted pain management with CEO Maria Bennett
At DeviceTalks Minnesota 2019, SPR Therapeutics founder, president & CEO Maria Bennett spoke with DeviceTalks program manager Sarah Faulkner about the company’s FDA-cleared peripheral nerve stimulation system for pain management. Want to see these interviews live? Join us at DeviceTalks West – Dec. 9-10 in Santa Clara, Calif. Sarah: Could you tell us a little […]
Report: Cadence Neuroscience raises $15m for epilepsy device
Cadence Neuroscience reportedly raised $15 million in a Series A funding round earlier this month for the development of a neurostimulation device to treat epilepsy. The round was led by Jazz Venture Partners, while the Mayo Clinic also offered support and Cadence won grants from Epilepsy Foundation, according to a GeekWire report. Cadence is reportedly […]
9 early medical devices that will horrify or amaze you
The movie Frankenstein inspired eight-year-old Earl Bakken to consider how electricity could restore life and health to the human body. Bakken went on to invent the first external cardiac pacemaker and to co-found medtech giant Medtronic in 1949. Bakken’s fascination with the effects of electricity on the human body continued throughout his career, and he amassed a collection of […]
Trial: Cefaly wearable safe, effective in preventing migraines
A new clinical trial has shown that the Cefaly migraine treatment device is safe and effective for migraine prevention, according to manufacturer Cefaly Technology. Cefaly is an external trigeminal nerve stimulation device (e-TNS) that is magnetically connected to a self-adhesive electrode placed on the forehead. It sends micro-impulses through the electrode to the upper branch […]
FDA clears Sky Medical Technology’s Geko external neurostim device for peripheral blood clots
Sky Medical Technology said yesterday that it received FDA 510(k) clearance for its Geko electrostimulation device for preventing venous thrombosis. The Daresbury, England-based company’s Geko device is designed to stimulate the calf muscles to increase blood flow in the deep veins of the calf, preventing venous thrombosis in non-surgical patients at risk for venous thromboembolism. […]